免疫蛋白酶体亚基β5i通过上调RIG-I促进皮肌炎肌周束肌萎缩
该研究检测了16例皮肌炎患者肌肉中免疫蛋白酶体亚基β5i与维甲酸诱导基因I(RIG-I)的表达,发现二者显著升高且与肌病严重程度相关,并在体外证实β5i过表达通过上调RIG-I导致人骨骼肌成肌细胞活力下降,提示β5i与RIG-I可能参与皮肌炎肌周束肌萎缩的病理机制。
要点
- 皮肌炎患者肌肉中β5i与RIG-I表达显著升高,且与肌病严重程度相关。
- β5i过表达上调RIG-I、MuRF1、I型干扰素相关蛋白及NF-κB通路蛋白,降低成肌细胞活力。
- β5i抑制剂PR957可部分恢复β5i过表达后的成肌细胞活力。
核心结论
- 免疫蛋白酶体亚基β5i通过上调RIG-I促进皮肌炎肌周束肌萎缩,β5i与RIG-I可能成为皮肌炎治疗潜在靶点。
研究设计与样本
- 研究检测16例皮肌炎患者肌肉中β5i与RIG-I表达,采用PCR、蛋白质印迹和免疫组化,并用慢病毒转导在人骨骼肌成肌细胞中过表达β5i进行体外功能研究。
主要发现
- 皮肌炎患者肌肉中β5i与RIG-I表达显著升高,且与肌病严重程度密切相关。
- 免疫组化和免疫荧光显示β5i与RIG-I在肌周束肌纤维中明显共定位表达。
- 人骨骼肌成肌细胞中β5i过表达显著上调RIG-I、肌萎缩标志物MuRF1、I型干扰素相关蛋白(MxA和IFNβ)及NF-κB通路相关蛋白(pIκBα、pIRF3和pNF-κBp65)。
- β5i过表达后成肌细胞活力显著下降,β5i抑制剂PR957处理可部分恢复。
- pppRNA激活RIG-I可上调IFNβ和MuRF1并降低成肌细胞活力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Perifascicular atrophy is a unique pathological hallmark in dermatomyositis (DM)-affected muscles; however, the mechanism underlying this process remains unclear. In this study, we aimed to investigate the potential role of the immunoproteasome subunit β5i and retinoic acid-inducible gene-I (RIG-I) in DM-associated muscle atrophy. METHODS: The expression of β5i and RIG-I in the muscles of 16 patients with DM was examined by PCR, western blotting and immunohistochemistry. The associations between β5i and RIG-I expression levels and muscle disease severity were evaluated. Lentivirus transduction was used to overexpress β5i in human skeletal muscle myoblasts (HSMMs) and consequent cell functional changes were studied in vitro. RESULTS: β5i and RIG-I expression in the muscle of patients with DM was significantly increased and closely associated with muscle disease severity. Immunohistochemistry and immunofluorescence analyses showed the marked colocalised expression of β5i and RIG-I in perifascicular myofibres. β5i overexpression in HSMMs significantly upregulated RIG-I, the muscle atrophy marker MuRF1, type I IFN-related proteins (MxA and IFNβ) and NF-κB pathway-related proteins (pIκBα, pIRF3 and pNF-κBp65). In addition, the viability of HSMMs decreased significantly after β5i overexpression and was partly recovered by treatment with a β5i inhibitor (PR957). Moreover, activation of RIG-I by pppRNA upregulated IFNβ and MuRF1 and reduced the cell viability of HSMMs. CONCLUSION: The immunoproteasome subunit β5i promotes perifascicular muscle atrophy in DM via RIG-I upregulation; our findings suggest a pathomechanistic role of β5i and RIG-I in DM-associated muscle damage, highlighting these components as potential therapeutic targets for the treatment of DM.
引用
- Zhang L, Xia Q, Li W, et al. Immunoproteasome subunit β5i promotes perifascicular muscle atrophy in dermatomyositis by upregulating RIG-I. RMD Open. 2023. PMID: 36854567. doi:10.1136/rmdopen-2022-002818
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。